The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Arthritis & Rheumatism

• Publication date

  2000-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/1529-0131(200009)43:9<2073::AID-ANR19>3.0.CO;2-UPMID 11014359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice

  1999cited by this paper
• Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

  1998cited by this paper
• Arthritis and sepsis caused by Staphylococcus aureus: can the tissue injury be reduced by modulating the host's immune system?

  1998cited by this paper
• Septic arthritis following Staphylococcus aureus infection in mice lacking inducible nitric oxide synthase.

  1998cited by this paper
• Iron, lactoferrin and iron regulatory protein activity in the synovium; relative importance of iron loading and the inflammatory response

  1998cited by this paper
• Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

  1997cited by this paper
• Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

  1997cited by this paper
• Septic arthritis.

  1997cited by this paper
• Lactoferrin or a Fragment Thereof Inhibits the Endotoxin-Induced Interleukin-6 Response in Human Monocytic Cells

  1996cited by this paper
• The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis.

  1995cited by this paper
• Lactoferrin: a general review.

  1995cited by this paper
• Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.

  1994cited by this paper
• Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

  1994cited by this paper
• Transport of lactoferrin from blood to bile in the rat

  1994cited by this paper
• Biological role of lactoferrin.

  1992cited by this paper
• Experimental Staphylococcus aureus arthritis in mice

  1991cited by this paper
• Uptake and handling of iron from transferrin, lactoferrin and immune complexes by a macrophage cell line.

  1988cited by this paper
• Effects of purified iron-saturated human lactoferrin on spleen morphology in mice infected with Friend virus complex.

  1987cited by this paper
• Effect of iron chelation on inflammatory joint disease.

  1987cited by this paper
• Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts.

  1986cited by this paper
• Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes.

  1986cited by this paper
• Cerebral and ocular toxicity induced by desferrioxamine.

  1985cited by this paper
• The effect of synovial iron on the progression of rheumatoid disease. A histologic assessment of patients with early rheumatoid synovitis.

  1984cited by this paper
• Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen.

  1984cited by this paper
• Iron and rheumatoid disease.

  1982cited by this paper
• Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

  1981cited by this paper
• THE INVOLVEMENT OF LACTOFERRIN IN THE HYPOSIDEREMIA OF ACUTE INFLAMMATION

  1974cited by this paper

• Transcriptomic insights into early mechanisms underlying post-chikungunya chronic inflammatory joint disease

  2025cites this paper
• Molecular Mechanisms of Inhibitory Effects of Bovine Lactoferrin on Invasion of Oral Squamous Cell Carcinoma

  2023cites this paper
• Nutraceuticals in arthritis

  2021cites this paper
• Bovine lactoferrin enhances osteogenesis through Smad2/3 and p38 MAPK activation.

  2020cites this paper
• Generating Antibacterial Microporous Structures Using Micro fl uidic Processing

  2019cites this paper
• LTF, PRTN3, and MNDA in Synovial Fluid as Promising Biomarkers for Periprosthetic Joint Infection: Identification by Quadrupole Orbital-Trap Mass Spectrometry.

  2019cites this paper
• Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma.

  2019cites this paper
• Looking for a partner: ceruloplasmin in protein–protein interactions

  2019cites this paper
• Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.

  2018cites this paper
• Molecular mechanism of inhibitory effects of bovine lactoferrin on the growth of oral squamous cell carcinoma

  2018cites this paper
• Benefits of Whey Proteins on Human Health

  2017cites this paper
• Lactoferrin from Camelus dromedarius Inhibits Nuclear Transcription Factor-kappa B Activation, Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Stimulated Human Chondrocytes

  2016influential citation
• Significant antibacterial activity and synergistic effects of camel lactoferrin with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).

  2016cites this paper
• Innate Humoral Defense Factors

  2015cites this paper
• Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions

  2015cites this paper
• ISOLATION OPTIMIZATION AND CHARACTERIZATION OF KLUYVEROMYCES MARXIANUS FROM PANEER WHEY FOR BIOMASS PRODUCTION AND USE AS ORNAMENTAL FISH FEED

  2015cites this paper
• A Novel Murine Anti-Lactoferrin Monoclonal Antibody Activates Human Polymorphonuclear Leukocytes through Membrane-Bound Lactoferrin and TLR4

  2015cites this paper
• Lactoferrin

  2015cites this paper
• The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis.

  2014cites this paper
• Aerosolized bovine lactoferrin reduces lung injury and fibrosis in mice exposed to hyperoxia

  2014cites this paper
• Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis.

  2014cites this paper
• A current review of molecular mechanisms regarding osteoarthritis and pain.

  2013cites this paper
• Lactoferricin mediates anti‐inflammatory and anti‐catabolic effects via inhibition of IL‐1 and LPS activity in the intervertebral disc

  2013cites this paper
• Lactoferricin enhances BMP7-stimulated anabolic pathways in intervertebral disc cells.

  2013cites this paper
• Lactoferrin in Malignant Human Tumours: New Insights from an Immunohistochemical Meta-Analysis

  2013cites this paper
• Orally administered liposomal lactoferrin inhibits inflammation-related bone breakdown without interrupting orthodontic tooth movement.

  2013cites this paper
• Role of whey proteins in combating geriatric disorders

  2013cites this paper
• The anti-catabolic role of bovine lactoferricin in cartilage

  2013cites this paper
• The thermodynamic and binding properties of the transferrins as studied by isothermal titration calorimetry.

  2012cites this paper
• Molecular Mechanisms of the Inhibitory Effects of Bovine Lactoferrin on Lipopolysaccharide-mediated Osteoclastogenesis

  2012cites this paper
• Clinical studies of lactoferrin in children.

  2012cites this paper
• Biochemical Mediators Involved in Cartilage Degradation and the Induction of Pain in Osteoarthritis

  2012cites this paper
• Lactoferrin--50 years on.

  2012cites this paper
• Lactoferrin, a key molecule in immune and inflammatory processes.

  2012cites this paper
• Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art

  2012cites this paper
• Healthy Multifunctional Spectra of Milk Glycoproteins and Their Fragments - a Review Article

  2012cites this paper
• Clinical studies of lactoferrin in children11This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal's usual peer review process.

  2012cites this paper
• Lactoferrin delivery systems: approaches for its more effective use

  2011cites this paper
• Lactoferrin, a key molecule in immune and inflammatory processes11This article is part of Special Issue entitled Lactoferrin and has undergone the Journal’s usual peer review process.

  2011cites this paper
• Lactoferrin in human tumours: immunohistochemical investigations during more than 25 years

  2011cites this paper
• Liposomal drug formulations in the treatment of rheumatoid arthritis.

  2011cites this paper
• Human trial of liposomal lactoferrin supplementation for periodontal disease.

  2010cites this paper
• Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis

  2010cites this paper
• Secreted lactoferrin and lactoferrin-related peptides: insight into structure and biological functions.

  2010cites this paper
• Inhibition of neutrophil infiltration by a malleable protein matrix of lactic acid bacteria-fermented whey proteins in vivo

  2009cites this paper
• Nutritional roles of lactoferrin

  2009cites this paper
• The potential of liposomal drug delivery for the treatment of inflammatory arthritis.

  2009cites this paper
• ‘Iron‐saturated’ lactoferrin is a potent natural adjuvant for augmenting cancer chemotherapy

  2008cites this paper
• Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid

  2008influential citation
• Lactoferrin structure and functions.

  2008cites this paper
• Utilization of lactoferrin to fight antibiotic-resistant mammary gland pathogens.

  2008cites this paper
• Lactoferrin ameliorates symptoms of experimental encephalomyelitis in Lewis rats.

  2007cites this paper
• Innate Humoral Defense Factors

  2007cites this paper
• Designing Lipid Nanostructures for Local Delivery of Biologically Active Macromolecules

  2007cites this paper
• Fecal Lactoferrin Is a Sensitive and Specific Marker of Disease Activity in Children and Young Adults With Inflammatory Bowel Disease

  2007cites this paper
• Antibiotic properties and applications of lactoferrin.

  2007cites this paper
• Emerging Health Properties of Whey Proteins and Their Clinical Implications

  2007cites this paper
• Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: evidence for synergistic activity.

  2007cites this paper
• Whey proteins and peptides: beneficial effects on immune health

  2006cites this paper
• Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin.

  2006cites this paper
• Lactoferrin

  2005cites this paper
• Liposomalization of lactoferrin enhanced it's anti-inflammatory effects via oral administration.

  2005cites this paper
• Modular Transcriptional Activity Characterizes the Initiation and Progression of Autoimmune Encephalomyelitis1

  2005cites this paper
• Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis.

  2004cites this paper
• The therapeutic potential of lactoferrin

  2003cites this paper
• Bone and Joints

  2003cites this paper
• Wirkung von Lactoferrin auf den Organismus neonataler Hundewelpen

  2003cites this paper
• Iron chelation in chemotherapy.

  2003cites this paper
• Review: Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application

  2002cites this paper
• Antimicrobial and immunoregulatory functions of lactoferrin and its potential therapeutic application.

  2002cites this paper
• Enhanced Th1 Response to Staphylococcus aureus Infection in Human Lactoferrin-Transgenic Mice1

  2002influential citation
• The physiology of lactoferrin.

  2002cites this paper
• Liposomes as Possible Carriers for Lactoferrin in the Local Treatment of Inflammatory Diseases

  2001cites this paper
• Lactoferrin: Antimicrobial and Diagnostic Properties

  2001cites this paper
• Human lactoferrin: a novel therapeutic with broad spectrum potential

  2001cites this paper
• Bacteriostatic activity of human lactoferrin against Staphylococcus aureus is a function of its iron-binding properties and is not influenced by antibiotic resistance.

  2001cites this paper
• Antiviral Activity of Human Colostral Lactoferrin Against Herpes Simplex Virus Type 1

  year unknowncites this paper